Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-09

FDA Approved: ONDANSETRON — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approves Sun Pharmaceutical Industries' supplemental application for ondansetron, an antiemetic. The approval indicates a change to the approved ANDA for on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON)